HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olle Larsson Selected Research

SYT-SSX fusion protein

4/2003Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas.
8/2002The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.
6/2002Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.
1/2002Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olle Larsson Research Topics

Disease

45Neoplasms (Cancer)
08/2021 - 01/2002
10Uveal melanoma
11/2008 - 01/2002
8Synovial Sarcoma (Synovioma)
01/2019 - 06/2002
7Melanoma (Melanoma, Malignant)
06/2010 - 01/2002
6Neoplasm Metastasis (Metastasis)
12/2018 - 01/2002
5Sarcoma (Soft Tissue Sarcoma)
04/2016 - 01/2005
4Multiple Myeloma
04/2012 - 01/2006
3Chondrosarcoma
11/2021 - 02/2002
2Carcinogenesis
06/2022 - 04/2003
2Disease Progression
11/2021 - 06/2010
2Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 04/2012
2Carcinoma (Carcinomatosis)
01/2020 - 04/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 04/2015
2Choroidal Neovascularization
11/2008 - 06/2008
1Genomic Instability
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Lymphoma (Lymphomas)
01/2019
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2019
1Solitary Fibrous Tumors
01/2018
1Astrocytoma (Pilocytic Astrocytoma)
10/2017
1Hepatocellular Carcinoma (Hepatoma)
04/2016
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
04/2016
1Neutropenia
01/2016
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2015
1Benign Fibrous Histiocytoma (Dermatofibroma)
08/2014
1Adenocarcinoma
04/2012
1Colonic Neoplasms (Colon Cancer)
04/2012
1Glioblastoma (Glioblastoma Multiforme)
01/2010
1Collagenous Colitis
09/2008
1Bone Diseases (Bone Disease)
10/2007
1Hyperplasia
07/2007
1Vascular System Injuries
07/2007

Drug/Important Bio-Agent (IBA)

17picropodophyllinIBA
10/2017 - 01/2006
13Insulin (Novolin)FDA Link
01/2016 - 01/2002
11Insulin-Like PeptidesIBA
10/2017 - 07/2003
7Insulin-Like Growth Factor I (IGF-1)IBA
07/2016 - 01/2002
6IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2011 - 07/2005
5RNA (Ribonucleic Acid)IBA
01/2020 - 06/2002
5Biological ProductsIBA
01/2019 - 01/2002
5ParaffinIBA
06/2010 - 01/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2021 - 07/2004
4DNA (Deoxyribonucleic Acid)IBA
08/2021 - 02/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2008 - 06/2008
4SYT-SSX fusion proteinIBA
04/2003 - 01/2002
3Proteins (Proteins, Gene)FDA Link
04/2016 - 07/2002
3Messenger RNA (mRNA)IBA
06/2015 - 05/2006
3Imatinib Mesylate (Gleevec)FDA Link
11/2008 - 07/2004
3Tyrosine (L-Tyrosine)FDA Link
10/2004 - 01/2002
2Phosphotransferases (Kinase)IBA
06/2022 - 04/2013
2Biomarkers (Surrogate Marker)IBA
11/2021 - 04/2016
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2021 - 12/2018
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 01/2006
2Somatomedin Receptors (Somatomedin Receptor)IBA
01/2019 - 07/2008
2ErbB Receptors (EGF Receptor)IBA
08/2015 - 03/2012
2Insulin-Like Growth Factor II (Somatomedin A)IBA
07/2015 - 04/2012
2LigandsIBA
07/2015 - 04/2012
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
08/2014 - 10/2003
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2012 - 07/2003
2Pharmaceutical PreparationsIBA
04/2012 - 10/2007
2Cyclin D1IBA
10/2011 - 07/2002
2EnzymesIBA
01/2011 - 04/2003
2AntibodiesIBA
11/2008 - 12/2005
2Cisplatin (Platino)FDA LinkGeneric
11/2008 - 06/2008
2Fluorouracil (Carac)FDA LinkGeneric
11/2008 - 06/2008
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2008 - 02/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2008 - 06/2008
2Extracellular Matrix ProteinsIBA
11/2008 - 02/2006
2ParaproteinsIBA
10/2007 - 01/2006
1Transcription Factors (Transcription Factor)IBA
06/2022
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2020
1Anaplastic Lymphoma KinaseIBA
01/2019
1Verteporfin (Visudyne)FDA Link
01/2019
1ASP3026IBA
01/2019
1Carrier Proteins (Binding Protein)IBA
01/2018
1Histone Deacetylase InhibitorsIBA
04/2016
1Histone Deacetylases (Histone Deacetylase)IBA
04/2016
1Carboplatin (JM8)FDA LinkGeneric
04/2015
1GemcitabineFDA Link
04/2015
1Genetic Markers (Genetic Marker)IBA
02/2015
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2014
1Protein Kinase CIBA
08/2014
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
08/2014
1Dasatinib (BMS 354825)FDA Link
04/2013
1tyrosine receptor (receptor, tyrosine)IBA
04/2013
1src-Family KinasesIBA
04/2013
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2011
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
10/2011
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2010
1CollagenIBA
09/2008
1Ligases (Synthetase)IBA
07/2008
1Antineoplastic Agents (Antineoplastics)IBA
06/2008
1Small Interfering RNA (siRNA)IBA
04/2007

Therapy/Procedure

8Therapeutics
11/2021 - 07/2002
4Drug Therapy (Chemotherapy)
08/2021 - 02/2006
1Molecular Targeted Therapy
06/2022
1Ligation
01/2020
1Neoadjuvant Therapy
01/2020
1Radiotherapy
04/2012
1Heterologous Transplantation (Xenotransplantation)
06/2008